4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001209191-23-054170
Options or other derivatives
- Chief Business Officer acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Krebs Stephanie Chief Business Officer | 2023-11-01 | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | D | ||
Loading xslF345X05/doc4.xml…